Cardiomyopathy with Mitochondrial Damage Associated with Nucleoside Reverse-Transcriptase Inhibitors

Authors:

Abstract
In July 2000, a 58-year-old man infected with the human immunodeficiency virus (HIV) began treatment with highly active antiretroviral therapy, which initially consisted of zidovudine, lamivudine, and ritonavir-boosted indinavir. After three months, a buffalo hump, anemia, and proximal muscle weakness developed, and the regimen was therefore switched to stavudine, lamivudine, and nevirapine. Because of pain in his legs, stavudine was replaced with abacavir three months later.